Roche
Roche, Stratipath Ink Deal to Distribute Breast Cancer Digital Pathology Solution
Stratipath Breast risk stratifies breast cancer by analyzing digitized histopathology slides of breast cancer tissue.
Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment
The companion diagnostic assay, for a drug under development by Syndax, will identify acute myeloid leukemia patients with an NPM1 mutation.
The firm recently started treating patients in a Phase I trial of its pol theta helicase inhibitor and filed an IND for its Werner helicase-targeted drug candidate.
Genentech Winds Down Cancer Immunology Group Amid Shifts in Science
The firm will fold the group's discovery functions into a unified oncology department and aims to assist affected employees.
Sangamo, Genentech Ink Deal to Advance Genomic Medicines for Alzheimer's, Other Neurological Diseases
Sangamo exclusively licensed certain technology to Genentech, which it will use to develop tau-directed medicines.